Appili Therapeutics

company

About

Appili Therapeutics is an anti-infective pharmaceutical development company.

  • 1 - 10

Details

Last Funding Type
Seed
Last Funding Money Raised
$3.06M
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2015
Number Of Employee
1 - 10
Operating Status
Active

Appili Therapeutics is an anti-infective pharmaceutical development company. Our approach lies in matching unmet medical needs with opportunities for more effective solutions that range from improvements in established therapies to entirely new classes of anti-infectives.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$10.69M $2.15M
Appili Therapeutics has raised a total of $10.69M $2.15M in funding over 2 rounds. Their latest funding was raised on Feb 7, 2018 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 7, 2018 Seed $4.33M 1 Innovacorp Detail
Oct 23, 2017 Seed $3.06M 1 Innovacorp Detail
Dec 21, 2016 Seed $2.15M 1 Innovacorp Detail
May 25, 2016 Seed $3.30M 1 Detail

Investors

Number of Lead Investors
Number of Investors
3
1
Appili Therapeutics is funded by 1 investors. Innovacorp are the most recent investors.
Investor Name Lead Investor Funding Round
Innovacorp Yes Seed